Abdullah Zeki KARASU
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Anabilim Dalı
Araştırma alanları: Sağlık Bilimleri, Tıp, Dahili Tıp Bilimleri, İç Hastalıkları, Gastroenteroloji-(hepatoloji), Cerrahi Tıp Bilimleri, Patoloji, Temel Tıp Bilimleri, Endokrinoloji ve Metabolizma Hastalıkları, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Yayınlar
- Risk Factors for Primary Sclerosing Cholangitis Recurrence Following Liver Transplantation: A Multicenter Retrospective Analysis (2026)
- De Novo Malignancies after Liver Transplantation: A Multicenter Cohort Study of Incidence, Timing, and Outcomes* (2026)
- Comparison of MELD, MELD-Na, and MELD 3.0 scoring systems for transplant prioritization in the Turkish population: A multicenter study (2026)
- TASL practice guidance for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease (MASLD) (2026)
- Portal vein thrombosis increases short-term mortality among hospitalized patients with cirrhosis in a global cohort (2026)
- Terlipressin Treatment for Acute Esophageal Variceal Bleeding: Bolus or Infusion? (2025)
- Pre-transplant predictors of 3-Month survival following liver transplantation for acute liver failure in adult and pediatric patients in Türkiye (2025)
- Ornidazole-Induced Liver Injury: The Clinical Characterization of a Rare Adverse Reaction and Its Implications from a Multicenter Study (2025)
- Changing Trends in the Etiology of Cirrhosis in Türkiye: A Multicenter Nationwide Study (2024)
- Mushroom Intoxication in Türkiye: A Nationwide Cohort Study Based on Demographic Trends, Seasonal Variations, and the Impact of Climate Change on Incidence (2024)
- Outcomes of Patients with Acute Hepatotoxicity Caused by Mushroom-Induced Poisoning (2023)
- Karaciğer biyopsisi endikasyonlarında ve histopatolojik tanılarda yıllar içindeki değişim: 7 yıllık tek merkez deneyimi (2022)
- A single center experience: Liver biopsy results during a year (Liver biopsy results) (2022)
- The effect of clinicopathologic findings of hepatocellular carcinoma on posttransplant survival: a multcenter cohort from TASL liver transplantation special interest group (2022)
- Ten-year single center experience in hepatotoxicity due to mushroom poisoning (2022)
- Trends and causes of etiology in adult liver transplant patients: multicenter study (2022)
- Characteristics of patients with hepatocellular carcinoma: A multicenter study (2022)
- Ornidazol ile İlişkili Hepatotoksisite: Son 10 Yılda Hastaneye Yatırılan 24 Hastanın Değerlendirilmesi (2021)
- Farklı karaciğer hastalıklarında non-invaziv fibrozis göstergelerinin karaciğer biyopsisi ile uyumu ve birbirleriyle Karşılaştırılması (2021)
- Kan testi parametrelerinin eklenmesi Fibroscan’ın karaciğer fibrozisini tahmin değerini arttırmamaktadır (2021)
- Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation (2021)
- Outcomes of Patients with Acute Hepatotoxicity Caused by Mushroom-Induced Poisoning (2021)
- Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients (2021)
- Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000-20000 IU/ml with ALT 1-2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT (2021)
- Covid-19 in Liver Transplant Recipients: A National Cohort (2021)
- Infections developing in patients undergoing liver transplantation: Recipients of living donors may be more prone to bacterial/fungal infections (2021)
- Steatotic and Steatohepatitic Hepatocellular Carcinomas Features in a Series With Predominantly Viral Etiology (2021)
- Etiology of Cirrhosis in Turkey: A National Cohort Study (2021)
- Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation (2021)
- Standardized versus nonstandardized pharmacologic treatment for hepatorenal syndrome (2021)
- The COVID-19 pandemic: Clinical practice advice for gastroenterologists, hepatologists, and liver transplant specialists (2020)
- Neutrophil/Monocyte Ratio: A new predictor of in hospital mortality in patients with spontaneous ascites infections (2020)
- Outcomes following deceased and live donor livertransplantation for the indication of acute liver failure: amulticenter experience (2020)
- KARACİĞER TRANSPLANTLI HASTALARDA HEPATİT E VİRÜS IGG SEROPREVELANSI: RETROSPEKTİF TEK MERKEZ DENEYİMİ (2020)
- Nonalkolik yağlı karaciğer hastalığında histolojik progresyon ile klinik ve laboratuvar parametrelerin ilişkisi (2020)
- HEPATİK ENSEFALOPATİYİ ÖNGÖRDÜRMEDE HEMOGRAM PARAMETRELERİ BİZE NELER SÖYLÜYOR? (2019)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- The Efficacy of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir with or without Ribavirin in Patients with Hepatitis C Undergoing Chronic Haemodialysis: A Single Center Experience (2019)
- Nonalkolik Yağlı Karaciğer Hastalığı ve Karaciğer Nakli (2019)
- Paritaprevir/Ritonavir/OmbitaSvir/Dasabuvir/Ribavirin treatment in HCV infected chronic hemodialysis patients: a single centereded experience (2019)
- Can we predict hepatic encephalopathy? What do the hemogram parameters tell us? (2019)
- Decrease in HbA1c accounts for the rapid decline in the measurement of liver stiffness by transient elastography in diabetic patients (2019)
- Karaciğer, safra kesesi ve safra yolu kanserlerinde epidemiyoloji ve sağ kalım özellikleri (2019)
- Karaciğer Nakli Yapılan Hastalarda Gelişen Enfeksiyonlar:Ege Üniversitesi Tıp Fakültesi Karaciğer Nakli KonseyiDeneyimi (2018)
- Karaciğer Nakli Yapılan Hastalarda Gelişen Enfeksiyonlar: Ege Üniversitesi Tıp Fakültesi Karaciğer Nakli Konseyi Deneyimi (2018)
- Güncel Bilgiler Eşliğinde Kolelitiazis Tedavisinde Laparaskopik ve Açık Kolesistektominin Yeri (2018)
- Türkiye Viral Hepatit Önleme ve Kontrol Programı” “Sağlık Bakanlığı Yayın No, Ankara (2018)
- Graft-Versus-Host-Disease after Living-Donor Liver Transplantation (2018)
- Increased Peripheral Platelet Count is Unrelated to Decreased Liver Fibrosis Score Following lamivudine Treatment of Patients with Chronic Hepatitis B (2018)
- Böbrek Nakli Hastalarında Hepatit C Virüs Enfeksiyonunun Paritaprevir-Ritonavir-Ombitasvir-Dasavubuvir (prOD) ile Tedavisi (2017)
- EFFICIACY OF LEDİPASVİR AND SOFOSBUVİR WİTH/WİTHOUT TREATMENT OF CHRONIC HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE RESULT OF A MULTICENTER TURKISH EARLY ACCES PROGRAM (2017)
- Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients? (2017)
- Hepatitis B immune globulin and HBV-related liver transplantation (2016)
- A Comparison of Prognostic Scoring Systems in Turkish Alcoholic Hepatitis Patients (2016)
- Comparison of Haemostatic Effects of Surgicel and Chitosan Using a Model of Exodontia in Patients With Cirrhosis (2014)
- Histological Sub Classification of Liver Cirrhosis with Laennec Staging System and Correlation with Clinical Findings (2014)
- The Association Between Skin Findings and Transplantation Period in Liver Transplant Recipients (2013)
- Telbivudin May Cause Increased Polineuropathy/Myopathy in Liver Transplant Recipients (2013)
- Early onset, linezolid induced severe liver injury, case report and review of the literature (2012)
- The relationship between HBV-DNA level and histology in patients with naive chronic HBV infection. (2011)
- 399 DELTA VIRUS COINFECTION DOES NOT INCREASE, BUT HCV COINFECTION INCREASE THE HBSAG LOSS, IN CHRONIC HBV INFECTION (2011)
- Efficacy of fractionated plasma separation and adsorption system (Prometheus) for treatment of liver failure due to mushroom poisoning. (2010)
- Nonalkolik Yağlı Karaciğer Hastalığında Histolojik Progresyonla Klinik ve Laboratuar Değişkenler Arasındaki İlişkinin Değerlendirilmesi. (2010)
- Kronik Hepatit B Virüs İnfeksiyonunun Lamivudin İle Tedavisinde Uzun Dönem Sonuçları (2009)
- Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease. (2009)
- FIBROSIS SHOULD BE INCLUDED INTO THE NON- ALCOHOLIC STEATOHEPATITIS SCORING SYSTEM FOR BEING MORE PROGNOSTICATIVE (2009)
- Prognozu daha iyi belirlemek için nonalkolik steatohepatit skoruna fibrozis eklenmelidir (2009)
- Common SPINK-1 mutations do not predispose to the development of non-alcoholic fatty liver disease (2009)
- Kronik Viral Hepatit B Tedavisinde Naiv Hastalarda Entekavir Tedavisinin Etkinliğinin Değerlendirilmesi (2009)
- İzmir’de yapılan hepatitli hasta ve hasta yakınlarını bilgilendirme toplantısı sonuçları (2009)
- Hepatik Ensefalopati Tedavisinde L-Ornitin L-Aspartat infüzyonunun etkinliği: ön çalışma sonuçları (2009)
- Association Between Hepatitis B and Hepatocellular Carcinoma Recurrence in Patients Undergoing Liver Transplantation (2008)
- Urgent adult-to-adult right lobe living donor liver transplantation for acute liver failure; a single center experience from Turkey. (2007)
- Osteoporosis is a important problem in which period after liver transplantation? (2007)
- Long-term effects of alendronate therapy on bone loss after liver transplantation (2007)
- Liver biopsy: Is the pain for real or is it only the fear of it? (2007)
- Results of endoscopic management of anastomotic biliary strictures after orthotopic liver transplantation. (2006)
- Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: one year follow-up after 48 weeks of treatment. (2006)
- Results of endoscopic management of anastomotic biliary strictures after orthotopic liver transplantation. (2006)
- Two-Year Interferon Therapy with Or without Ribavirin in Chronic Delta Hepatitis (2005)
- Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. (2005)
- Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. (2005)
- Interferon–Lamivudine Combination is No Better than Lamivudine Alone in Anti-Hbe-Positive Chronic Hepatitis B (2004)
- Low-Dose Hepatitis B Immune Globulin and Higher-Dose Lamivudine Combination to Prevent Hepatitis B Virus Recurrence after Liver Transplantation (2004)
- SIROLIMUS RESCUE THERAPY FOR NEUROTOXICITY AND NEPHROTOXICITY SECONDARY TO THE USE OF CALCINEURIN INHIBITORS AFTER THE ORTHOTOPIC LIVER TRANSPLANTATION (2004)
- Cardiovascular problems in cirrhotic patients. (2004)
- Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. (2003)
- Interferon re-treatment for resistance to lamivudine plus interferon treatment. (2003)
- Clinicopathological features of hepatitis C virus infection in dialysis and renal transplantation. (2003)
- Predictors of hepatic steatosis in living liver donors (2003)
- Interferon re-treatment for resistance to lamivudine plus interferon treatment. (2003)
- Risk factors associated with changes in oxygenation and pulse rate during colonoscopy. (2002)
- Sustained response to the interferon therapy in HBeAg(+) chronic hepatitis B is not sustained (2002)
- Severe toxic hepatitis associated with amoxycillin and clavulanic acid (2001)
- Nitroimidazole-induced chronic hepatitis (2001)
- Hepatosellüler kanserde periferik kan hücrelerinde AFP mRNA’sı (2001)
- Ursodeoxycholic acid can be used as a steroid-tapering drug in the treatment of autoimmune hepatitis (2001)
- Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C (2001)
- Primary lymphoma of rectum with a fistula to ileum (2001)
- Treatment of HBV DNA Negative chronic hepatitis B patients with high transaminases. (2000)